T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood
Accuracy of T2MR in diagnosing candidemia in critically ill patients: a prospective observational study
T2Candida® to guide antifungal and length of treatment of candidemia in a pediatric multivisceral transplant recipient
Implementation of the T2 Biosystems T2Bacteria Panel in a level-one trauma center, safety net hospital
Incorporating T2Candida testing into rational antifungal (AF) management: A successful pilot study of diagnostic stewardship directed toward specific intensive care unit patients at-risk for sepsis due to invasive candidiasis
T2Candida (T2MR) versus Beta-D-Glucan for preemptive antifungals stewardship in the intensive care unit
Novel T2Candida Panel assay compared to blood cultures for detection of candidemia in transplant and non-transplant patients
Diagnosing candidemia with the T2Candida Panel: An instructive case of septic shock in which blood cultures were negative